ClearLine MD(TM) Secures $5.5MM Funding for Commercialization of ClearLine IV(TM)

WOBURN, Mass., Jan. 9, 2018 -- (Healthcare Sales & Marketing Network) -- ClearLine MD, a medical device company focused on reducing the impact of iatrogenic Air Burden to patients and improving the safety and effectiveness of intravenous (IV) therapy, tod... Devices, Venture Capital ClearLine MD, ClearLine, iatrogenic Air, intravenous
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news